New treatment for joint damage after injuries
Official title: Engineered Biotherapeutic Agent for Treatment of Post-Traumatic Osteoarthritis
Funded at Provizigen LLC · NIH-11259928 · Data updated 2026-11-12
This study is testing a new injectable treatment called HydroGEN for people with post-traumatic osteoarthritis, which can happen after joint injuries like ACL tears, to help reduce pain and inflammation while supporting cartilage healing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Provizigen LLC NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 25, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $54,999 |
| NIH project number | 3R41AR083738-01S1 |
| Project ID | NIH-11259928 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have experienced acute joint injuries, particularly those involving the anterior cruciate ligament (ACL), and are at risk of developing post-traumatic osteoarthritis.
✕Less likely to help
Patients with chronic osteoarthritis not related to acute joint injuries may not benefit from this research.
What this research studies
This research focuses on developing a novel injectable hydrogel treatment for post-traumatic osteoarthritis (PTOA), a condition that arises after joint injuries like ACL tears. The hydrogel, named HydroGEN, is designed to deliver anti-inflammatory and cartilage-protecting molecules directly into the joint space, aiming to reduce pain and inflammation while promoting cartilage repair. The approach has shown promising results in preclinical models, suggesting it could significantly alter the course of PTOA if successful.
Why it matters
Potential benefit: If successful, this research could provide a new treatment option that slows or prevents the progression of post-traumatic osteoarthritis, potentially reducing the need for joint replacement surgeries.
How similar studies have gone: Other research has shown success with similar injectable therapies in managing joint conditions, indicating that this approach has potential based on prior findings.
Where this research is happening
-
Provizigen LLC
New York, United States Active
Researchers
- Principal investigator: Chaugule, Jui Shivaji — Provizigen LLC
- Study coordinator: Chaugule, Jui Shivaji
Related research
Other NIH-funded projects on the same topics.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Identifying OA subtypes and early warning signs before joint damage
This grant asks researchers to find early, invisible clues of osteoarthritis subtypes so we can target treatments before joints are damaged.
-
Digital biomarkers to guide personalized rehab after ACL injury
Aims to use wearable sensors and phone videos to predict early osteoarthritis risk after ACL surgery so rehabilitation can be tailored to each patient.
-
Aberrant mechano-oxygen coupling linked to zinc-rich mineralization in osteoarthritis
Aims to understand how abnormal joint forces affect cartilage and bone, causing zinc-rich mineral deposits and harmful blood vessel growth in osteoarthritis.
-
Notch signaling in TMJ osteoarthritis: uncovering mechanisms and new targets
Researchers are studying how Notch signaling affects TMJ osteoarthritis to identify new ways to protect and repair the jaw joint.
-
Nanoparticles delivering an sPLA2 blocker for knee osteoarthritis
This project uses tiny, drug-filled nanoparticles to deliver an sPLA2-blocking medicine into the knee to reduce inflammation and slow knee osteoarthritis in people with painful knee OA.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.